Pull up a chair, dear, and let's talk about the long road of drug discovery. Researchers test enormous numbers of compounds, and most of them don't work out. Every experiment costs time and money. SymNexusPredict helps researchers decide which compounds to test first.
It learns from your past experimental results which properties of compounds tended to go with success: activity against a target, solubility, stability or safety signals. Compounds are described by measurable features and molecular descriptors your chemists already use. For new candidates, SymNexusPredict estimates the likelihood of success and explains which properties drive the estimate. Promising candidates rise to the top of the list.
This is a research tool, and I'll say so plainly. Predictions guide which experiments to run; they never replace laboratory confirmation. Safety and efficacy are established by experiments and trials, under the rules that apply. SymNexusPredict simply helps make the path more efficient.
The explanations are valuable to chemists. Seeing which properties push an estimate up or down can suggest how to modify a compound. It's like having a colleague who has read every past experiment. Ideas come faster.
Uncertainty is part of the answer. SymNexusPredict gives ranges and confidence, so researchers know which predictions are firm and which are guesses. Uncertain predictions can be tested to learn the most. That's a thoughtful way to use a research budget.
Getting started means sharing past experimental data with compound descriptors and outcomes. We'll help format it and choose sensible features with your chemists. The text-reading tools in the SymNexus family can also work directly with molecular notation if you prefer. Every lab's data is a little different, and we'll adapt.
We test predictions honestly on compounds it didn't learn from, ideally including new chemical families, which is the hardest and most realistic test. Comparisons with simple baselines show the real value. Results are shared openly with your scientists. Good science demands it.
Researchers remain in charge. They design the experiments, interpret results and decide which paths to pursue. SymNexusPredict offers a well-informed second opinion. The science stays with the scientists.
Each new experiment adds to what it knows. As results come in, the predictions improve. Your lab's data becomes an ever more valuable asset. Knowledge accumulates rather than sitting in scattered files.
Imagine testing the fifty most promising compounds first rather than five hundred at random. Imagine faster progress toward medicines that help people. That's the careful promise of predictive research tools. It's a privilege to support such work.
Please visit the platform page to see how a record is scored and its drivers explained. Picture the same view for a candidate compound. When you're ready, we'll discuss a pilot with your research team. I'd be honoured to help.
